KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Invested Capital (2017 - 2025)

Guardant Health (GH) has disclosed Invested Capital for 9 consecutive years, with -$99.3 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 28.89% to -$99.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$99.3 million through Dec 2025, up 28.89% year-over-year, with the annual reading at -$99.3 million for FY2025, 28.89% up from the prior year.
  • Invested Capital hit -$99.3 million in Q4 2025 for Guardant Health, up from -$354.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $847.0 million in Q1 2021 to a low of -$354.5 million in Q3 2025.
  • Historically, Invested Capital has averaged $178.0 million across 5 years, with a median of $113.5 million in 2023.
  • Biggest five-year swings in Invested Capital: soared 253.27% in 2024 and later crashed 18838.31% in 2025.
  • Year by year, Invested Capital stood at $645.0 million in 2021, then tumbled by 90.67% to $60.2 million in 2022, then skyrocketed by 163.68% to $158.7 million in 2023, then plummeted by 188.0% to -$139.6 million in 2024, then grew by 28.89% to -$99.3 million in 2025.
  • Business Quant data shows Invested Capital for GH at -$99.3 million in Q4 2025, -$354.5 million in Q3 2025, and -$305.5 million in Q2 2025.